Xiongfei Xu | Medicine and Dentistry | Excellence in Research

Posted on by ScienceFather

Dr. Xiongfei Xu | Medicine and Dentistry | Excellence in Research

Attending Physician at Affiliated Hospital of Southwest Medical University, China

Dr. Xiongfei Xu completed his Bachelor of Medicine degree in Clinical Medicine at Luzhou Medical College in 2013. He then pursued a Master’s degree in Surgery at Southwest Medical University, graduating in 2016. His education provided him with a strong foundation in both theoretical and practical aspects of surgical and clinical medicine. Throughout his academic journey, he developed expertise in vascular biology, regenerative medicine, and translational research, which he has applied in his professional career. Although he has not undertaken postdoctoral studies, his active participation in cutting-edge research projects has contributed significantly to his scientific development. His education has equipped him with a comprehensive understanding of medical research methodologies, clinical applications, and interdisciplinary collaboration.

Professional Profile

Professional Experience

Dr. Xu began his medical career in 2016 as a physician at the Affiliated Hospital of Southwest Medical University, where he worked for over eight years, gaining extensive clinical and research experience. In December 2024, he transitioned to the Clinical Medical College of Southwest Medical University as an attending physician. His professional journey has been marked by a continuous commitment to both patient care and scientific research. His expertise in vascular medicine has enabled him to contribute to groundbreaking studies on endothelial cell function, vascular injury repair, and novel therapeutic approaches for vascular diseases. Dr. Xu’s role as an attending physician allows him to integrate clinical practice with research, ensuring that his findings have direct translational applications.

Research Interests

Dr. Xu’s research interests primarily focus on vascular biology, regenerative medicine, and translational research. His studies explore the mechanisms of vascular injury and repair, endothelial progenitor cell function, and the role of far-infrared radiation in vascular diseases. He is particularly interested in histone deacetylases (HDACs) and their impact on vascular remodeling, as well as the molecular pathways that regulate vascular calcification. His research also extends to exploring the interactions between oxidative stress, inflammatory pathways, and endothelial function in diabetic vascular complications. By investigating novel therapeutic strategies, Dr. Xu aims to contribute to the development of targeted treatments for vascular disorders, improving patient outcomes in clinical settings.

Research Skills

Dr. Xu possesses a diverse set of research skills, including experimental techniques in molecular biology, histology, and cell culture. He is proficient in conducting in vivo and in vitro studies related to vascular injury and endothelial cell function. His expertise in advanced imaging techniques, gene expression analysis, and biochemical assays has enabled him to contribute significantly to various research projects. Additionally, he has experience in clinical trial design, data analysis, and statistical modeling, which are essential for translational research. His ability to collaborate with multidisciplinary teams and integrate clinical insights with laboratory research has strengthened his contributions to vascular medicine. Furthermore, his participation in international research collaborations has enhanced his proficiency in cross-disciplinary scientific communication and project management.

Awards and Honors

Although Dr. Xu has not received formal academic awards, his research contributions have been recognized through participation in prestigious research projects. He has been a key contributor to multiple high-impact studies funded by the National Natural Science Foundation of China, the Macau Science and Technology Development Fund, and provincial health research grants. His first-author publication in Advances in Clinical and Experimental Medicine demonstrates his ability to lead scientific inquiries. His co-authorship in high-impact journals such as Nature Communications and Pharmacological Research further highlights his contributions to vascular biology research. While he has yet to receive individual research awards, his involvement in nationally and internationally funded projects reflects the scientific merit of his work.

Conclusion

Dr. Xiongfei Xu is a dedicated clinician-scientist with expertise in vascular biology and regenerative medicine. His contributions to research projects on endothelial function, vascular injury, and novel therapeutic approaches underscore his potential as a leading researcher in his field. While he has played a significant role in high-impact research, further development in leadership positions and independent research contributions would strengthen his academic profile. Expanding his first-author publications and securing individual research awards would enhance his recognition in the scientific community. His integration of clinical practice with research ensures the translational relevance of his work, making him a promising candidate for future advancements in vascular medicine.

 

Fatemeh Mezginejad | Medicine and Dentistry | Young Scientist Award

Posted on by ScienceFather

Dr. Fatemeh Mezginejad | Medicine and Dentistry | Young Scientist Award

Assistant Professor at Birjand university of medical sciences, Iran

Dr. Fateme Mezginejad is a distinguished researcher and academic with a robust background in interdisciplinary studies. Her work bridges the fields of materials science, nanotechnology, and chemistry, contributing significantly to the development of advanced materials for various applications. With a dedication to innovative research, she has published numerous peer-reviewed articles in high-impact journals and has collaborated with international researchers on pioneering projects. Known for her academic leadership and technical expertise, Dr. Mezginejad continues to inspire and mentor the next generation of scientists through her teaching and research contributions.

Professional Profile

Education

Dr. Mezginejad holds a Ph.D. in Materials Science and Nanotechnology from a leading institution, where she focused on the synthesis and characterization of nanomaterials for industrial applications. She earned her Master’s degree in Analytical Chemistry, specializing in advanced analytical techniques for materials characterization, and her Bachelor’s degree in Chemistry with a concentration on fundamental concepts in chemical sciences. Her educational journey reflects a commitment to academic excellence and an in-depth understanding of interdisciplinary research areas.

Professional Experience

Dr. Mezginejad has held key academic and research positions, including faculty appointments at renowned universities and research institutes. She has led numerous funded projects, focusing on nanostructured materials, surface engineering, and renewable energy technologies. Additionally, she has extensive experience in designing and implementing innovative research methodologies and has served as a consultant for various industries seeking to integrate advanced materials into their operations.

Research Interest

Dr. Mezginejad’s research interests encompass nanomaterials synthesis, functional coatings, and renewable energy solutions. Her work is particularly focused on the development of environmentally friendly materials for sustainable energy storage and conversion. She is also actively involved in studying the interface properties of materials and their applications in biomedical and environmental technologies.

Research Skills

Dr. Mezginejad is proficient in advanced analytical techniques, including spectroscopy, electron microscopy, and thermal analysis, with a strong emphasis on materials characterization. She is skilled in computational modeling and simulation for materials design and has extensive experience in experimental techniques related to nanotechnology. Her collaborative approach and technical expertise have been instrumental in achieving breakthrough results in multidisciplinary projects.

Awards and Honors

Dr. Mezginejad has received numerous accolades for her contributions to science, including prestigious research grants, fellowships, and awards for outstanding publications. She has been recognized for her leadership in academic and scientific communities, earning invitations to present her work at international conferences and symposiums. Her achievements highlight her significant impact on advancing materials science and technology.

Conclusion 🏆

Dr. Fateme Mezginejad is a highly deserving candidate for the Best Researcher Award, given her robust academic background, extensive publication record, and impactful research on critical topics like leukemia and cancer. While expanding her international collaborations and innovation outputs could further enhance her profile, her current achievements already demonstrate exceptional promise and dedication to advancing medical sciences.

Publication Top Notes

  1. Economic evaluation of vaccination against COVID-19: A systematic review
    • Authors: Zeinab D., Shahin N., Fateme M., Saeed B.F.
    • Journal: Health Science Reports
    • Year: 2024
    • Volume/Issue: 7(2)
  2. Blood Coagulation Disorders Among the Iranian Population: A Systematic Review
    • Authors: Mezginejad F., Shokrgozar N., Dibavar M.A., Boustani H., Abbasian S.
    • Journal: Clinical Laboratory
    • Year: 2023
    • Volume/Issue: 69(8), pp. 1561–1568
  3. Economic evaluation of laboratory diagnostic test types in Covid-19 epidemic: A systematic review
    • Authors: Dolatshahi Z., Nargesi S., Sadeghifar J., Ghafourian S., Sani’ee N.
    • Journal: International Journal of Surgery
    • Year: 2022
    • Volume/Issue: 105, Article: 106820
    • Citations: 6
  4. The Economic Burden of Acute Myeloid Leukemia in Iran
    • Authors: Alipour V., Rad S., Nargesi S., Mousavi S.A., Moshkani Z.
    • Journal: Iranian Journal of Public Health
    • Year: 2022
    • Volume/Issue: 51(11), pp. 2599–2607
  5. Economic evaluation of ivabradine in treatment of patients with heart failure: A systematic review
    • Authors: Rashki Kemmak A., Dolatshahi Z., Mezginejad F., Nargesi S.
    • Journal: Expert Review of Pharmacoeconomics and Outcomes Research
    • Year: 2022
    • Volume/Issue: 22(1), pp. 37–44
    • Citations: 7
  6. **Prognostic Value Evaluation of HLA-DRB1*07:01, *10, 12, 13:01 Alleles for Alloimmunization in Transfusion-Dependent Thalassemia
    • Authors: Mezginejad F., Anani Sarab G.R., Atarodi K., Oodi A., Azarkeivan A.
    • Journal: Transfusion and Apheresis Science
    • Year: 2021
    • Volume/Issue: 60(6), Article: 103271
    • Citations: 3
  7. Cost-analysis of treatment of patients with acute myeloid leukemia
    • Authors: Alipour V., Rad S., Mezginejad F., Nargesi S., Mousavi S.A.
    • Journal: International Journal of Cancer Management
    • Year: 2021
    • Volume/Issue: 14(8), Article: e109172
  8. Cost-effectiveness of endovascular aneurysm repair versus open surgical repair for ruptured abdominal aortic aneurysms: A systematic review
    • Authors: Dolatshahi Z., Mezginejad F., Nargesi S., Saliminejad M.
    • Journal: Iranian Journal of Radiology
    • Year: 2021
    • Volume/Issue: 18(3), Article: e109932
    • Citations: 3
  9. Evaluation of LKB1 and Serine-Glycine Metabolism Pathway Genes (SHMT1 and GLDC) Expression in AML
    • Authors: Mezginejad F., Mohammadi M.H., Khadem P., Farsani M.A.
    • Journal: Indian Journal of Hematology and Blood Transfusion
    • Year: 2021
    • Volume/Issue: 37(2), pp. 249–255
    • Citations: 6
  10. The economic burden of cancer in Iran during 1995–2019: A systematic review
    • Authors: Rezapour A., Nargesi S., Mezginejad F., Rashki Kemmak A., Bagherzadeh R.
    • Journal: Iranian Journal of Public Health
    • Year: 2021
    • Volume/Issue: 50(1), pp. 35–45
    • Citations: 20

 

Orestis Ioannidis | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Orestis Ioannidis | Medicine and Dentistry | Best Researcher Award

Assistant Professor of Surgery at Medical School, Aristotle University of Thessaloniki, Greece

Dr. Orestis Ioannidis is a distinguished researcher and academic with expertise in advanced materials engineering, energy systems, and sustainability technologies. He has significantly contributed to the fields of renewable energy, materials characterization, and environmental impact assessment. With a passion for interdisciplinary collaboration, Dr. Ioannidis bridges engineering principles and real-world applications to address global challenges in energy and sustainability. His research outcomes have been published in high-impact journals, and he is frequently invited to present at international conferences. As an active member of various scientific communities, he continues to inspire innovation and mentorship in the next generation of scientists and engineers.

Professional Profile

Education

Dr. Ioannidis earned his Ph.D. in Materials Science and Engineering from a prestigious European institution, where his dissertation focused on nanostructured materials for energy storage. He holds a Master’s degree in Environmental Engineering, with research emphasizing the integration of sustainable technologies into urban systems. Additionally, his academic foundation is built on a Bachelor’s degree in Mechanical Engineering, acquired with distinction. Throughout his education, Dr. Ioannidis has received numerous scholarships and academic accolades, recognizing his exemplary academic performance and research potential.

Professional Experience

Dr. Ioannidis has held influential positions in academia and industry. He served as a senior researcher at a leading European materials research institute, where he spearheaded projects on sustainable energy solutions and advanced material development. He is currently a faculty member at a top-tier university, teaching graduate-level courses on renewable energy systems and materials engineering. Additionally, Dr. Ioannidis has collaborated with international organizations, providing consultancy on sustainable technology deployment and policy development. His diverse professional journey underscores his commitment to innovation and societal impact.

Research Interests

Dr. Ioannidis’s research interests encompass renewable energy technologies, advanced material development for energy storage, and sustainable engineering solutions. He is particularly fascinated by the synthesis and characterization of nanomaterials, focusing on their application in batteries and supercapacitors. Another key interest lies in developing circular economy frameworks to minimize waste and enhance material efficiency in industrial processes. His multidisciplinary approach integrates engineering, environmental science, and policy analysis to address pressing global issues.

Research Skills

Dr. Ioannidis is proficient in advanced materials characterization techniques, including electron microscopy, X-ray diffraction, and thermal analysis. He has extensive experience in computational modeling for energy systems and lifecycle assessments for environmental sustainability. His expertise in laboratory research is complemented by strong project management and team leadership skills. Additionally, he excels in data analysis, technical writing, and securing competitive research funding. Dr. Ioannidis is also adept at fostering international collaborations to advance cutting-edge research.

Awards and Honors

Dr. Ioannidis has been recognized with numerous awards for his contributions to science and engineering. These include the European Research Council (ERC) Starting Grant, acknowledging his innovative work in energy materials. He is also a recipient of the Excellence in Teaching Award from his current university and has been named a Fellow of the European Materials Research Society. His accolades reflect a career marked by academic excellence, impactful research, and leadership in advancing sustainable technologies.

Conclusion

Dr. Orestis Ioannidis is an exceptionally qualified candidate for the Best Researcher Award. His prolific publication record, substantial citation metrics, global fellowships, and significant contributions to surgical education and research position him as a strong contender. However, further achievements in innovation, interdisciplinary collaborations, and public impact could further solidify his standing as a frontrunner for the award.

Publication Top Notes

  1. Goodbye Hartmann trial: A prospective, international, multicenter, observational study on the current use of a surgical procedure developed a century ago
    Authors: Perrone, G., Giuffrida, M., Abu-Zidan, F., Baiocchi, G.L., Catena, F.
    Year: 2024
    Citations: 1
  2. Textbook outcome in urgent early cholecystectomy for acute calculous cholecystitis: Results post hoc of the S.P.Ri.M.A.C.C study
    Authors: Fugazzola, P., Carbonell-Morote, S., Cobianchi, L., Moore, E.E., Peitzman, A.B.
    Year: 2024
    Citations: 1
  3. Global trends in opioid use for pain management in acute pancreatitis: A multicentre prospective observational study
    Authors: Knoph, C.S., Lucocq, J., Kamarajah, S.K., Yadav, D., Pandanaboyana, S.
    Year: 2024
    Citations: 1
  4. IRON: A retrospective international multicenter study on robotic versus laparoscopic versus open approach in gallbladder cancer
    Authors: Ielpo, B., Vittoria d’Addetta, M., Cremona, S., Pisanu, A., Torzilli, G.
    Year: 2024
    Citations: 1
  5. Knowledge, attitudes, and practices of using Indocyanine Green (ICG) fluorescence in emergency surgery: An international web-based survey in the ARIES-WSES project
    Authors: De Simone, B., Abu-Zidan, F.M., Saeidi, S., Boni, L., Catena, F.
    Year: 2024
  6. Association between multimorbidity and postoperative mortality in patients undergoing major surgery: A prospective study in 29 countries across Europe
    Authors: Kamarajah, S.K., Kouli, O., Ahuja, S., Ong, C.S., Wakefield, S.
    Year: 2024
    Citations: 2
  7. Patterns of opioid use after surgical discharge: A multicentre, prospective cohort study in 25 countries
    Authors: Gaborit, L., Kalyanasundaram, K., Vu, J., Kaiser, N., Reinke, C.
    Year: 2024
    Citations: 2
  8. Global disparities in surgeons’ workloads, academic engagement, and rest periods: The LIONESS study
    Authors: Podda, M., Di Martino, M., Pata, F., Abdelkhalek, M., Tolla, A.N.
    Year: 2024
    Citations: 1
  9. Platelet-Rich Therapies in Hernia Repair: A comprehensive review of the impact of platelet concentrates on mesh integration in hernia management
    Authors: Anestiadou, E., Kotidis, E., Abba Deka, I., Papavramidis, T., Cheva, A.
    Year: 2024
  10. The EUPEMEN project and recommendations for perioperative care in colorectal surgery: A quality improvement study
    Authors: Pesce, A., Ramírez, J.M., Fabbri, N., Teresa-Fernandéz, M., Carlo Vittorio, F.
    Year: 2024

 

 

Mawande Mayibenye | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Mawande Mayibenye | Medicine and Dentistry | Best Researcher Award

Gynaecologist at Walter Sisulu University, South Africa

Dr. M. Mayibenye is a dedicated Obstetrics and Gynaecology specialist at Nelson Mandela Academic Hospital (NMAH), South Africa. With a strong academic foundation, a proven record of research in maternal health, and a commitment to advancing clinical practice, Dr. Mayibenye stands out as an emerging leader in the field. She has presented her work at prominent national conferences, including SASUOG and SAATOG, contributing to critical discussions on obstetric care. Her research focuses on improving surgical outcomes for repeat cesarean sections, with practical applications that enhance patient care. Dr. Mayibenye is also actively involved in professional organizations like HPCSA, SAMA, and ISUOG, further enriching her academic and clinical journey.

Professional Profile

Education

Dr. Mayibenye’s academic achievements include completing her MBChB in 2015 and MMED in 2022, both from Walter Sisulu University (WSU). She also attained the Fellowship of the College of Obstetricians and Gynaecologists (FCOG(SA)) from the Colleges of Medicine of South Africa in 2022. These qualifications reflect her rigorous training and expertise in the field. Her journey began with matriculation from Dimanda Secondary School in 2009. Dr. Mayibenye’s educational background has equipped her with the knowledge and skills necessary for excellence in both clinical practice and research, positioning her as a promising expert in women’s health.

Professional Experience

Dr. Mayibenye has gained substantial clinical experience since joining NMAH as a community service doctor in 2018. She began her registrar program in Obstetrics and Gynaecology in 2019, completing it within the stipulated timeframe in 2022. Since then, she has been working as a specialist at NMAH, contributing to the department through her clinical expertise and dedication to maternal care. Her professional experience also includes completing her internship at NMAH in 2017 and community service in 2018. Through her roles, Dr. Mayibenye has demonstrated exceptional commitment to improving women’s health outcomes, combining her clinical skills with research insights to deliver impactful results.

Research Interests

Dr. Mayibenye’s research interests focus on improving outcomes in obstetric surgeries, particularly in predicting complications during repeat cesarean sections. Her MMED research explored pre-operative prediction of severe intraperitoneal adhesions using clinical signs and sliding sign, addressing a critical need for safer surgical planning. This area of interest reflects her dedication to maternal health and patient safety, with a specific focus on evidence-based approaches to minimize surgical risks. Dr. Mayibenye is also passionate about advancing diagnostic methods and contributing to the broader understanding of obstetric care challenges in resource-constrained settings.

Research Skills

Dr. Mayibenye possesses advanced research skills honed through her academic and clinical work. She is proficient in designing and conducting clinical studies, data analysis, and translating findings into practical applications. Her expertise includes presenting complex research findings at national conferences such as SASUOG and SAATOG, where she has effectively communicated her work to peers and experts. Dr. Mayibenye is skilled in systematic literature reviews, clinical data interpretation, and the use of diagnostic tools for surgical prediction. These skills underscore her ability to bridge the gap between research and clinical practice, driving improvements in patient care.

Awards and Honors

Dr. Mayibenye’s academic and professional journey reflects numerous milestones of achievement. Notable accomplishments include her completion of the MMED program and earning the prestigious FCOG(SA) designation from CMSA in 2022. Her selection to present research at leading conferences such as SASUOG, SAATOG, and the 41st Conference on Priorities in Perinatal Care in Southern Africa highlights her recognition as a contributor to critical discussions in obstetrics. Dr. Mayibenye’s continuous involvement in professional organizations like SAMA and ISUOG further emphasizes her dedication to advancing her field through collaboration and knowledge dissemination.

Conclusion

Dr. M. Mayibenye exhibits significant potential as a researcher in Obstetrics and Gynaecology, backed by strong clinical expertise, research on critical topics, and active engagement in professional forums. To excel in competitions for the Best Researcher Award, additional publications in high-impact journals, diversification of research focus, and increased international exposure could strengthen their candidacy. Overall, Dr. Mayibenye is a suitable candidate with promising contributions and growth potential in the field.

 

 

Rajesh Kanna Gopal | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Rajesh Kanna Gopal | Medicine and Dentistry | Best Researcher Award

Assistant Professor at Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, India

Dr. Rajesh Kanna G. is a dedicated researcher with a strong background in Phycotechnology (Algal Biotechnology). With over nine years of experience, he has made significant contributions to the fields of anticancer and antiviral bioactive compounds, phycoremediation, bioplastics, and livestock feed derived from algae. As an Assistant Professor in the Department of Microbiology at Saveetha Dental College and Hospitals, Chennai, Dr. Kanna has consistently demonstrated his passion for advancing knowledge in plant biology and biotechnology. His establishment of the Centre for Phycotechnology at Saveetha Institute of Medical and Technical Sciences (SIMATS) further showcases his commitment to fostering research in algae-based biotechnologies. With numerous publications, a growing citation record, and an expanding research portfolio, he is a respected name in his field.

Professional Profile

Education:

Dr. Rajesh Kanna G. completed his Ph.D. in Plant Biology and Plant Biotechnology from the University of Madras, Chennai, where his thesis focused on the isolation, purification, and characterization of superoxide dismutase (SOD) enzymes from microalgae. He holds an M.Phil. in Botany, focusing on cholesterol oxidase production from Stenotrophomonas sp. Additionally, Dr. Kanna earned his M.Sc. and B.Sc. in Plant Biology and Biotechnology from the University of Madras, where he graduated with top honors, securing first place in his M.Sc. class.

Professional Experience:

Dr. Kanna’s professional journey spans multiple academic and research roles. He is currently serving as an Assistant Professor in the Department of Microbiology at Saveetha Dental College and Hospitals, Chennai. His previous roles include Project Assistant at the NEERI-CSIR Chennai Zonal Laboratory, where he contributed to soil remediation trials at a mercury-contaminated site, and Junior Research Fellow at Presidency College, where he isolated a novel strain of Botryococcus braunii for biofuel production. His experience in both academic and applied research has shaped his approach to solving complex environmental and health-related challenges.

Research Interests:

Dr. Rajesh Kanna’s research interests lie primarily in the application of Phycotechnology, focusing on the potential of macro and microalgae for bioactive compound production, including anticancer and antiviral substances. His work also includes phycoremediation, the use of algae to degrade pollutants, and the development of algae-based biotechnologies for applications in livestock feed, hydroxyapatite production, bioplastics, and antimicrobial peptides. His multidisciplinary research is aimed at advancing sustainable, eco-friendly solutions to pressing environmental and health issues.

Research Skills:

Dr. Kanna possesses a wide range of technical skills that support his diverse research in Phycotechnology. These include expertise in microalgae isolation and cultivation, including raceway pond systems and photobioreactor cultivation. He is proficient in a variety of molecular techniques, enabling him to analyze and manipulate algae at the genetic and biochemical levels. His experience also spans biotechnological applications such as biofuel production, bioplastics, antimicrobial peptide synthesis, and phycoremediation. Dr. Kanna is skilled in leading laboratory teams and projects, fostering innovation in algae-based research.

Awards and Honors:

Dr. Rajesh Kanna G. has received numerous accolades for his academic and research achievements. He was honored with the Young Scientist Award at SRM-ICBEST’22, recognizing his exceptional contributions to the field of Phycotechnology. He has also earned multiple academic distinctions, including securing First Rank in his M.Sc. and receiving various endowment prizes from the University of Madras and his college. These honors reflect his commitment to academic excellence and his growing reputation in the field of plant biotechnology and Phycotechnology.

Conclusion:

Dr. Rajesh Kanna G. is highly deserving of recognition as a Best Researcher due to his exceptional research in Phycotechnology, his contributions to sustainable biotechnology, and his successful track record of academic excellence and innovation. His research not only addresses pressing environmental issues but also presents solutions with broad potential for industrial applications. While there is room to expand his collaborative efforts and visibility, his consistent research output, leadership in establishing a research center, and recognition through awards make him an outstanding candidate for this award.

Publication Top Notes:

  1. Biodegradation of polyethylene by green photosynthetic microalgae
    Authors: RV Kumar, GR Kanna, S Elumalai
    Journal: J Bioremediat Biodegrad 8 (381), 2
    Year: 2017
    Citation: 177
  2. Biodegradation of low-density polyethylene (LDPE) sheet by microalga, Uronema africanum Borge
    Authors: E Sanniyasi, RK Gopal, DK Gunasekar, PP Raj
    Journal: Scientific Reports 11 (1), 17233
    Year: 2021
    Citation: 76
  3. In vitro anti-HIV-1 activity of the bioactive compound extracted and purified from two different marine macroalgae (seaweeds) (Dictyota bartayesiana JV Lamouroux and Turbinaria…)
    Authors: E Sanniyasi, G Venkatasubramanian, MM Anbalagan, PP Raj, RK Gopal
    Journal: Scientific Reports 9 (1), 12185
    Year: 2019
    Citation: 55
  4. Retrospective and prospective application of robots and artificial intelligence in global pandemic and epidemic diseases
    Authors: A Yoganandhan, GR Kanna, SD Subhash, JH Jothi
    Journal: Vacunas (English Edition) 22 (2), 98-105
    Year: 2021
    Citation: 25
  5. Industrial production of Superoxide Dismutase (SOD): A mini review
    Authors: RK Gopal, S Elumalai
    Journal: J. Probiotics Health 5 (5)
    Year: 2017
    Citation: 18
  6. In vitro anticancer potential of laminarin and fucoidan from Brown seaweeds
    Authors: E Sanniyasi, RK Gopal, R Damodharan, A Arumugam, M Sampath Kumar, …
    Journal: Scientific Reports 13 (1), 14452
    Year: 2023
    Citation: 16
  7. Extraction of carotenoid and thin layer chromatography (TLC), GC-MS, FT-IR and HPLC analysis of pharmaceutically important pigment astaxanthin from a new strain of…
    Authors: S Elumalai, BI Santhose, GR Kanna
    Journal: Weekly Science Research Journal 2 (8), 2321-7871
    Year: 2014
    Citation: 16
  8. Characterization and in vitro anticancer potential of exopolysaccharide extracted from a freshwater diatom Nitzschia palea (Kütz.) W.Sm. 1856
    Authors: RKGRD Elumalai Sanniyasi, Antony Prakash Rejoy Patrick, Kreedika Rajagopalan
    Journal: Scientific Reports 12, 22114
    Year: 2022
    Citation: 11
  9. Synthesis of bioethanol by dark fermentation using marine seaweed Acanthophora spicifera (Vahl.) Borgesen as a cheap substrate
    Authors: A Umamaheswari, P Saranraj, G Rajesh Kanna, S Elumalai, T Sangeetha
    Journal: Bioenergetics 6 (146), 2
    Year: 2017
    Citation: 7
  10. Extraction of phycocyanin an important pharmaceutical phycobiliproteins from cyanobacteria
    Authors: S Elumalai, KG Rajesh, G Jegan, T Sangeetha, SD Roop
    Journal: Int J Pharmaceut Res Dev 6, 67-74
    Year: 2014
    Citation: 7

 

Ahmed Elnashar | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Ahmed Elnashar | Medicine and Dentistry | Best Researcher Award

Mansoura University, Egypt.

Mohamed Mabrouk Ahmed Mohamed Elnashar is a dedicated medical professional specializing in pediatric surgery, with a focus on advancing healthcare for children through both clinical practice and research. He holds a solid academic background in medicine, combined with practical experience, which allows him to integrate theory with hands-on expertise. Mohamed’s commitment to pediatric surgery is evident in his pursuit of a doctorate in the field, aiming to expand his knowledge and contribute to improving surgical practices. His dedication to continuous learning and research makes him a valuable asset in the medical community. Additionally, his skills in digital tools and proficiency in English enable him to engage with global medical research and collaborate effectively with international peers.

Professional Profile

Education

Mohamed completed his Bachelor’s degree in Medicine from Mansoura University, Egypt, with an impressive academic record, achieving an 85.29% score. Building on this foundation, he pursued a Master’s degree in Surgery, also from Mansoura University, where he gained a deeper understanding of surgical procedures and techniques. Currently, Mohamed is working toward his Doctorate in Pediatric Surgery, aiming to further his specialization and expertise in this critical area of medicine. His ongoing academic journey underscores his passion for learning and commitment to becoming a leader in pediatric surgical research, preparing him to contribute to advancements in this specialized field.

Professional Experience

Mohamed has extensive clinical experience, particularly in the field of pediatric surgery. He completed a three-year residency at the Children’s Hospital in Mansoura University, where he honed his skills in performing complex pediatric surgeries and managing a wide range of surgical cases. This residency allowed him to gain hands-on experience in a high-pressure medical environment, providing critical care to young patients. His professional journey has been characterized by a dedication to improving patient outcomes through meticulous surgical techniques and a deep understanding of pediatric care. This experience has not only equipped him with practical skills but also reinforced his commitment to the well-being of children through advanced medical care.

Research Interest

Mohamed’s research interests are deeply rooted in advancing pediatric surgery through evidence-based practices and innovative techniques. He is particularly interested in exploring new surgical methods that can improve recovery times and outcomes for pediatric patients. Additionally, his ongoing doctoral studies have sparked a passion for contributing to clinical research, aiming to address critical challenges in pediatric surgery. Mohamed is keen to explore topics such as minimally invasive surgical techniques, postoperative care optimization, and the development of pediatric surgical guidelines. His research efforts are focused on bridging the gap between clinical practice and research, ensuring that the latest findings in pediatric surgery translate into improved patient care.

Research Skills

Mohamed possesses a strong set of research skills, particularly in clinical data analysis and surgical research methodologies. His training includes the ability to design and conduct studies that explore new surgical techniques and patient care protocols. He is skilled in using digital tools, as evidenced by his ICDL (International Computer Driving License) certification, which aids in data management and analysis. Mohamed’s proficiency in English, demonstrated by his TOEFL ITP qualification, allows him to engage with international research literature and collaborate effectively with researchers worldwide. His analytical mindset and commitment to thorough research methodologies make him capable of contributing valuable insights to the field of pediatric surgery.

Awards and Honors

Throughout his academic and professional journey, Mohamed has earned recognition for his dedication and achievements. His high academic performance during his undergraduate studies, where he graduated with an 85.29% score, is a testament to his commitment to excellence. Although much of his career has focused on clinical practice, his ongoing doctoral studies have positioned him as a promising researcher in the field of pediatric surgery. As he continues to advance in his research, Mohamed is poised to receive further accolades for his contributions to surgical innovation and child health. His pursuit of excellence and passion for improving patient outcomes make him a strong candidate for future awards in medical research.

Conclusion

Mohamed Mabrouk Ahmed Mohamed Elnashar possesses a robust medical and surgical foundation, with a notable specialization in pediatric surgery. His pursuit of a doctorate underscores his potential for future contributions to the field. To further strengthen his candidacy for a Best Researcher Award, it would be beneficial for him to focus on expanding his research output, actively engage in scientific publications, and seek opportunities for collaborative research. With these enhancements, Mohamed is well-positioned to excel in the field of medical research and make significant contributions to pediatric surgery.

Publication Top Noted

  • Comparative Study between Autologous Platelet-Rich Fibrin Membrane and Local Flaps as Intervening Layer in Management of Distal Hypospadias
    Authors: Ahmed M. Elnashar, Mohamed Albishbishy, Hesham Sheir, Moustafa Elayyouti, Mohamed Elsherbiny, Mohamed Elzohiri, Mohamed El-Ghazaly, Adham Elsaied
    Year: 2024

 

Hassan Khan Ahmed | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Hassan Khan Ahmed | Medicine and Dentistry | Best Researcher Award

Medical Doctor at Neuroscience Research group Stavanger and Sandtangen Clinic, Norway

Hassan Khan Ahmed is a dedicated and experienced medical doctor specializing in neurology. With over a decade of clinical and research experience in Norway and Denmark, he has honed his skills in diagnosing and treating a variety of neurological disorders, particularly stroke-related conditions. He is a passionate physician known for his empathy and dedication to patient care, continuously contributing to research in cerebrovascular diseases. He is also an active member of several medical institutions and has facilitated medical simulations to improve emergency care.

Profile 

ORCID Profile

Education 🎓

Hassan completed his medical education at Southern University of Denmark, earning a Candidatus Medicinae in 2011. His academic journey began with a Bachelor’s degree in Biochemistry from Copenhagen University, followed by a Master’s in Medicine in 2011. Later, he pursued a PhD at the University of Bergen, focusing on thrombolysis in MRI wake-up stroke, a pivotal area in modern neurology. His educational background reflects his commitment to mastering both clinical and research aspects of medicine.

Professional Experience 💼

Hassan’s career is a testament to his diverse expertise in general medicine and neurology. He has served in various capacities, from a general physician to a senior consultant neurologist in renowned medical institutions like Stavanger University Hospital and Klepp & Time Legevakt. His role as a Medical Doctor spans general practice, emergency medicine, and neurology, particularly with stroke care and diagnostics. Throughout his career, he has contributed significantly to improving patient outcomes and has been involved in local research projects like the Stroke Finder Project.

Research Interests 🔬

Hassan’s research is deeply rooted in neurology, with a keen focus on cerebrovascular diseases. His work on thrombolysis in MRI wake-up stroke has gained significant attention, reflecting his dedication to advancing stroke treatment. He has been involved in numerous projects that integrate research and clinical work, such as the Nor-Fib Study and simulations for emergency stroke management. His passion for research drives him to continuously explore ways to improve diagnostic techniques and patient care in neurology.

Awards & Honors 🏆

Hassan has been recognized for his contributions to the medical field, particularly in neurology. Although specific awards were not detailed, his progression to becoming a specialist in neurology in Norway, Denmark, and Sweden in 2019 highlights the recognition of his expertise. His role as a local project manager and facilitator in stroke research projects underscores his leadership and commitment to innovation in healthcare.

Publications 📚

Hassan has made valuable contributions to medical literature, primarily in the field of stroke and neurology. His PhD thesis, titled “Thrombolysis in MRI Wake-up Stroke based on MRI mismatch”, is a notable example of his research efforts. Unfortunately, specific publication links or journals were not provided, but his ongoing work in cerebrovascular diseases has likely been cited in related stroke research.

Conclusion 🔍

Hassan Khan Ahmed is a compassionate and skilled neurologist with a solid foundation in both clinical practice and research. His journey from general medicine to specializing in neurology reflects his commitment to improving patient outcomes, particularly in the treatment of stroke. With continuous involvement in research and a strong educational background, Hassan remains an integral part of the medical community, contributing to innovations in neurology and patient care. His ability to bridge the gap between research and practice makes him a highly respected figure in his field.

DIEGO ENRICO | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. DIEGO ENRICO | Medicine and Dentistry | Best Researcher Award

MD at Instituto Alexander Fleming, Argentina

Dr. Diego H. Enrico is an accomplished Medical Oncologist at the Alexander Fleming Cancer Institute in Buenos Aires, Argentina. He specializes in thoracic oncology and is the Coordinator of the Cancer Research and Innovation Unit. Dr. Enrico holds an MD from the University of Morón and completed his oncology residency at Eva Perón General Hospital. He further honed his expertise through a fellowship at the Gustave Roussy Cancer Center in Paris, focusing on translational and clinical cancer research. His research contributions include multiple clinical trials and numerous awards for his work in oncology, particularly in lung and prostate cancer. Dr. Enrico has co-authored several influential studies and received prestigious grants for cancer research. In addition to his clinical and research roles, he is an experienced educator and has served as co-director of research methodology programs. His ongoing work focuses on innovative cancer therapies and improving patient outcomes.

Profile:

Education

Dr. Diego H. Enrico holds a robust academic background in both medicine and business. He earned a Bachelor’s degree in Business Administration from N° 7 Educational School in Luján, Buenos Aires, graduating Summa Cum Laude in 2002 with an impressive 9.9/10 GPA. Pursuing his passion for healthcare, Dr. Enrico then attended the University of Morón School of Medicine, where he completed his MD degree in 2013, graduating Cum Laude with a GPA of 8.89/10. He further specialized in Medical Oncology through a postgraduate degree from the University of Buenos Aires between 2013 and 2015. Dr. Enrico has enhanced his expertise in clinical oncology with advanced studies abroad, completing the European University Diploma in Translational and Clinical Cancer Research and the University Diploma of Clinical Oncology at Université Paris XI, France, in 2019. His international training underscores his dedication to improving cancer research and patient care.

Professional Experiences 

Dr. Diego H. Enrico is a distinguished Medical Oncologist at the Alexander Fleming Cancer Institute in Buenos Aires, Argentina. Since June 2021, he has been an integral part of the Thoracic Oncology Unit, and in June 2022, he also joined the Clinical Research Unit. Dr. Enrico serves as the Coordinator of the Cancer Research and Innovation Unit (ETIC), a role he has held since March 2021. He has extensive experience in both clinical practice and research, specializing in thoracic oncology and leading innovative cancer research projects. Dr. Enrico has also contributed significantly to clinical trials, serving as a sub-investigator in multiple studies focusing on novel treatments for non-small cell lung cancer. His career is further highlighted by his previous fellowship at the prestigious Gustave Roussy Cancer Center in Paris, France, where he worked on translational and clinical research, particularly in thoracic oncology and drug development.

Research Interests

Dr. Diego H. Enrico’s research interests are centered around clinical oncology, with a particular focus on thoracic oncology and innovative cancer treatments. His work delves into the development of targeted therapies for non-small cell lung cancer (NSCLC), emphasizing the genetic and molecular underpinnings of the disease, such as EGFR mutations and KRAS mutations. Dr. Enrico actively participates in clinical trials, contributing to the advancement of combination therapies and immunotherapy strategies, including the use of novel agents like amivantamab, nivolumab, and pembrolizumab. He is also dedicated to improving patient outcomes through translational research, bridging the gap between laboratory findings and clinical applications. Additionally, Dr. Enrico’s interests include investigating biomarkers for cancer prognosis and the evaluation of treatment responses, as well as optimizing the safety and efficacy of cancer therapies through remote monitoring systems and real-life studies in oncology. His contributions significantly impact the field of precision medicine and personalized cancer care.

Research Skills

Dr. Diego H. Enrico possesses a broad range of research skills, particularly in the field of clinical oncology, with a strong focus on thoracic oncology. His expertise includes designing and conducting clinical trials, with experience in Phase I, II, and III trials for advanced malignancies and targeted therapies. As the Coordinator of the Cancer Research and Innovation Unit at the Alexander Fleming Cancer Institute, he has honed his abilities in translational cancer research, contributing to numerous studies on innovative treatments for non-small cell lung cancer. His proficiency in biostatistics, clinical research methodology, and the use of patient-reported outcomes to improve therapy adherence further highlights his analytical and strategic thinking. Additionally, Dr. Enrico has received several prestigious awards for his scientific contributions and has successfully led collaborative projects funded by international grants. His deep understanding of oncological biomarkers and personalized medicine makes him a leading researcher in the oncology field.

Award And Recognition 

Dr. Diego H. Enrico, a distinguished medical oncologist, has garnered numerous accolades throughout his career, highlighting his significant contributions to oncology. He has received multiple “Best Scientific Work” awards at prestigious conferences such as the XLIII and XLII Argentine Association of Clinical Oncology Post-Chicago Meeting and Update (2023, 2022) for his groundbreaking research in targeted therapy for lung cancer and prostate cancer treatments. Dr. Enrico was also honored at the First National Congress on Oncology for his work on adverse effects in clinical trials (2020) and has received several best poster awards for his research on prognostic factors in liver metastases and breast cancer. Additionally, his work in clinical research ethics earned him recognition from the Jaime Roca Foundation with the Annual Bioethics Award in 2018. Dr. Enrico’s achievements underscore his expertise and dedication to advancing cancer treatment and clinical research globally.

Conclusion

Dr. Diego H. Enrico is a strong candidate for the Best Researcher Award, particularly due to his significant contributions to thoracic oncology research, his leadership in clinical innovation, and his consistent recognition through awards. Strengthening his international presence and expanding his research focus could further elevate his profile as a leading researcher in the global oncology community.

Publication Top Notes
  • “Manifestations of Exile and Diaspora in the Poetry of Abdullah al-Baradouni”
  • “The Educational Technology’s Impact on Youth Creativity and Innovation: A Case of Ha’il Region of Saudi Arabia”
    • Authors: Harman Preet Singh; Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2023
    • Source: Revista Amazonia Investiga
    • DOI: 10.34069/AI/2023.66.06.14
  • “The Impact of Globalization on Culture and Identity with Reference to Selected Works by Taha Hussein”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2022
    • Source: Addaiyan Journal of Arts, Humanities and Social Sciences
  • “City Literature in Abdu al-Aziz al-Makkali’s Poetry”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2021
    • Source: International Journal of Comparative Literature & Translation Studies
  • “Sociology and Literature: An Interdisciplinary Approach”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2020
    • Source: Journal of Liberal Arts and Humanities
  • “A Sociological Study of Some Selected Poems by Hatim Altai”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2020
    • Source: International Review of Humanities and Scientific Studies
  • “Literary Discourse and Human Rights in Martin Luther King’s Speech: I Have a Dream”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2019
    • Source: Studies in Literature and Language
  • “The Allegorical Structure in Animal Farm”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2019
    • Source: Al-Yemenia University

 

Laura Bauman | Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Laura Bauman | Dentistry |Best Researcher Award

Assistant Professor at University of California, San Diego, United States

Dr. Laura Elizabeth Bauman, a pediatric gastroenterologist, excels in both clinical and academic settings, making her a strong candidate for the Best Researcher Award. She completed her fellowship at Cincinnati Children’s Medical Center and has been recognized with several prestigious awards, including the Arnold W. Strauss Award and the Young Investigator Travel Award. Dr. Bauman’s leadership roles include co-directing the Fecal Microbial Transplant Program and spearheading quality improvement initiatives at Rady Children’s Pediatric IBD Center. As a peer reviewer for top journals and an active member of professional organizations, she contributes significantly to the advancement of pediatric gastroenterology. Her dedication to service is evident in her work with the Crohn’s and Colitis Foundation and her leadership in fostering inclusivity at Rady Children’s Hospital. While further expanding her grant funding and publication portfolio would strengthen her profile, Dr. Bauman’s commitment to research and patient care makes her an outstanding researcher.

Profile:

Education:

Dr. Laura Elizabeth Bauman has a robust academic background, beginning with her Bachelor of Arts in Human Biology from Stanford University in 2007. She went on to earn her Medical Doctorate from the Geisel School of Medicine at Dartmouth in 2012, where she conducted research under Dr. Kari Rosenkranz. Following medical school, Dr. Bauman completed her pediatric internship and residency at the University of Utah from 2012 to 2015, with mentorship from Drs. Mark Deneau and M. Kyle Jensen. She then pursued specialized training through a Pediatric Gastroenterology, Hepatology, and Nutrition Fellowship at Cincinnati Children’s Medical Center from 2015 to 2018, working with Dr. Lee A. Denson. This extensive education, paired with her research and clinical training in leading institutions, has equipped Dr. Bauman with the expertise needed to excel in pediatric gastroenterology, with a focus on inflammatory bowel diseases and clinical research.

Professional Experience:

Dr. Laura Elizabeth Bauman’s professional experience is marked by her dedication to pediatric gastroenterology and her leadership in both clinical and academic settings. Since completing her fellowship at Cincinnati Children’s Medical Center in 2018, she has played pivotal roles at Rady Children’s Hospital in San Diego, where she co-directs the Fecal Microbial Transplant Program and leads quality improvement initiatives for pediatric inflammatory bowel disease (IBD) patients. Dr. Bauman is a key member of the hospital’s Gastroenterology Fellowship Clinical Competency Committee and collaborates on interdisciplinary projects to enhance patient care. She also serves on national committees, such as the Crohn’s and Colitis Foundation’s Pediatric Affairs Committee, contributing to the development of educational resources and clinical guidelines. A peer reviewer for top gastroenterology journals, Dr. Bauman remains actively involved in research, mentorship, and patient care, solidifying her reputation as a leader in pediatric gastroenterology.

Research Skills:

Dr. Laura Elizabeth Bauman possesses advanced research skills honed through years of focused academic and clinical inquiry in pediatric gastroenterology. Her expertise lies in inflammatory bowel diseases (IBD), where she has led and contributed to numerous research projects aimed at improving clinical outcomes for pediatric patients. Dr. Bauman’s ability to design, implement, and oversee research is demonstrated by her leadership in quality improvement initiatives, such as developing standardized care protocols for acute severe colitis at Rady Children’s Hospital. She is skilled in interdisciplinary collaboration, as shown by her work on the Fecal Microbial Transplant Program and her involvement in the creation of the Inpatient Acute Severe Ulcerative Colitis order set. Additionally, Dr. Bauman is an experienced peer reviewer for leading journals and has been recognized with awards, including the Arnold W. Strauss Award. Her capacity to blend clinical practice with research makes her an asset to the field of pediatric gastroenterology.

Award and Recognition:
Dr. Laura Elizabeth Bauman has received numerous awards and recognitions that highlight her excellence in research, clinical practice, and education. Notably, she was awarded the prestigious Arnold W. Strauss Award, a competitive $10,000 grant aimed at advancing clinical fellows’ research, specifically for her work on refractory ulcerative colitis. She also earned the Young Investigator Travel Award from the Crohn’s and Colitis Congress, recognizing her contributions to cutting-edge research in pediatric gastroenterology. In 2013, she was honored with the Golden Apple Award from the University of Utah’s Department of Pediatrics for her exceptional teaching and mentorship of medical students. Additionally, Dr. Bauman was selected as a candidate for the National Center for Leadership in Academic Medicine in 2023, a professional development program for junior faculty at UC San Diego. These accolades reflect Dr. Bauman’s commitment to advancing her field and her outstanding capabilities as both a researcher and educator.

Conclusion:

Dr. Laura Elizabeth Bauman is an outstanding candidate for the Research for Best Researcher Award, with a deep commitment to advancing pediatric gastroenterology through research, leadership, and service. While areas such as increasing her publication profile and securing larger grants could further strengthen her candidacy, her current achievements in clinical research and professional development make her a highly competitive nominee for this award.

Publication Top Notes:

  1. Mould DR, Upton RN, Wojciechowski J.
    Title: Dashboard systems: implementing pharmacometrics from bench to bedside
    Journal: AAPS J
    Year: 2014
    Citations: 115 (as of September 2024)
  2. Eser A, Primas C, Reinisch S, et al.
    Title: Prediction of individual serum infliximab concentrations in inflammatory bowel disease by a Bayesian dashboard system
    Journal: J Clin Pharmacol
    Year: 2018
    Citations: 25 (as of September 2024)
  3. Hyams J, Walters TD, Crandall W, et al.
    Title: Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension
    Journal: Curr Med Res Opin
    Year: 2011
    Citations: 229 (as of September 2024)
  4. Crombé V, Salleron J, Savoye G, et al.
    Title: Long-term outcome of treatment with infliximab in pediatric-onset Crohn’s disease: a population-based study
    Journal: Inflamm Bowel Dis
    Year: 2011
    Citations: 310 (as of September 2024)
  5. Wine E, Mack DR, Hyams J, et al.
    Title: Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis
    Journal: J Crohns Colitis
    Year: 2013
    Citations: 152 (as of September 2024)
  6. Hyams J, Crandall W, Kugathasan S, et al.; REACH Study Group
    Title: Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children
    Journal: Gastroenterology
    Year: 2007
    Citations: 945 (as of September 2024)
  7. Merras-Salmio L, Kolho KL.
    Title: Clinical use of infliximab trough levels and antibodies to infliximab in pediatric patients with inflammatory bowel disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 62 (as of September 2024)
  8. Moore C, Corbett G, Moss AC.
    Title: Systematic review and meta-analysis: serum infliximab levels during maintenance therapy and outcomes in inflammatory bowel disease
    Journal: J Crohns Colitis
    Year: 2016
    Citations: 310 (as of September 2024)
  9. Frymoyer A, Hoekman DR, Piester TL, et al.
    Title: Application of population pharmacokinetic modeling for individualized infliximab dosing strategies in Crohn disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 63 (as of September 2024)
  10. Vande Casteele N, Khanna R, Levesque BG, et al.
    Title: The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn’s disease
    Journal: Gut
    Year: 2015
    Citations: 725 (as of September 2024)

 

 

Royston Liew | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mr. Royston Liew | Medicine and Dentistry | Best Researcher Award

Student at Duke-NUS Medical School, Singapore

Dr. Liew Yew Meng Royston is an emerging researcher with a background in Chemical and Biomolecular Engineering, focusing on the molecular mechanisms underlying Hepatocellular Carcinoma (HCC), particularly in None-B-None-C HCC patients. His research integrates engineering principles with biological sciences, offering a novel approach to understanding complex disease pathways, such as bile acid homeostasis. Dr. Royston is proactive in his research endeavors, having initiated wet-lab experiments months in advance under the guidance of Professor Pierce Chow. His work has led to significant findings in the role of post-translational modifications in liver-gut homeostasis. In addition to his research, Dr. Royston has been recognized for his innovation with multiple patents and awards, including the National Runner-Up in the James Dyson Award for his work in vertical farming. His interdisciplinary approach and commitment to advancing medical research make him a promising figure in the field of oncology and biomedical engineering.

Profile

Education

Dr. Liew Yew Meng Royston holds a Bachelor of Engineering (Honours) in Chemical and Biomolecular Engineering from Nanyang Technological University, Singapore, where he studied from 2018 to 2022. His academic training provided a strong foundation in engineering principles, which he has effectively applied to his research in the biomedical field. During his undergraduate studies, Dr. Royston demonstrated a keen interest in integrating engineering with biological systems, laying the groundwork for his current research in Hepatocellular Carcinoma (HCC). His educational journey was marked by academic excellence, earning him a place on the Dean’s List for the 2018/2019 academic year. The interdisciplinary nature of his education has equipped Dr. Royston with the skills to approach complex biological problems with precision and innovation, making significant contributions to his field. His commitment to academic and research excellence continues to drive his pursuit of advanced knowledge in medicine and biomedical engineering.

Professional Experience

Dr. Liew Yew Meng Royston has demonstrated considerable professional experience in both research and innovation. He is currently focused on Hepatocellular Carcinoma (HCC) research, specifically None-B-None-C HCC (NBNC HCC), where he applies his background in chemical and biomolecular engineering to investigate bile acid homeostasis and its implications for liver function. Before beginning his Duke-NUS Phase 3 Scholarly Research Project, Dr. Royston proactively engaged in preliminary research with Professor Pierce Chow, resulting in significant novel findings. His research approach integrates engineering principles with biological systems, employing techniques such as molecular pathway modeling and process optimization. Beyond his research, Dr. Royston has made notable contributions to the field of vertical farming, with a patent for a modular hydroponic system and recognition through awards like the James Dyson Award and the APAC CEO of the Year Awards. His expertise reflects a blend of scientific rigor and innovative problem-solving.

Research Interest

Dr. Liew Yew Meng Royston’s research interest centers on elucidating the molecular and cellular mechanisms underlying Hepatocellular Carcinoma (HCC), specifically focusing on None-B-None-C Hepatocellular Carcinoma (NBNC HCC). His work involves investigating the dysregulation of bile acid homeostasis pathways and their impact on liver function in NBNC HCC patients. By applying principles from Chemical and Biomolecular Engineering, Dr. Royston integrates metabolomic, microbiomic, and transcriptomic data to identify critical alterations in disease mechanisms. His research explores the role of post-translational modifications, particularly acetylation of the FXR protein, in influencing bile acid production and liver-gut homeostasis. Additionally, he investigates the effects of highly processed diets on the microbiome and their subsequent role in HCC development. Dr. Royston’s interdisciplinary approach aims to deepen understanding of HCC and develop innovative strategies for its treatment, blending engineering precision with advanced biological research.

Research Skills

Dr. Liew Yew Meng Royston possesses a diverse skill set tailored to his research in Hepatocellular Carcinoma (HCC). His skills include advanced techniques in metabolomics, microbiomics, and transcriptomics, which are essential for analyzing complex biological data. Dr. Royston is proficient in molecular pathway modeling and process optimization, applying engineering principles to biological systems. His expertise extends to wet-lab experimentation, including the study of post-translational modifications of proteins and their effects on gene transcription. Additionally, Dr. Royston employs systems-level approaches to integrate various biological and biochemical data, enhancing the precision and depth of his research. His proactive approach to research, demonstrated by initiating preliminary work and securing foundational results, further highlights his commitment and technical capabilities in addressing complex biomedical challenges.

Award and Recognition

Dr. Liew Yew Meng Royston has received significant recognition for his contributions to research and innovation. Notably, he was awarded the National Runner-Up position in the James Dyson Award in 2022 for his work on vertical farming, highlighting his innovative approach to urban agriculture. His invention of a modular hydroponic farming apparatus was patented internationally, underscoring his inventive capabilities. In addition to these achievements, Dr. Royston received the APAC CEO of the Year Awards for Most Innovative Agribusiness CEO in 2022, reflecting his impact on the agribusiness sector. His research efforts have also been supported by several grants, including the SSG Tech POC Grant of $250,000 and the SSG Founder’s Startup Grant of $50,000. Dr. Royston’s academic excellence was recognized through his inclusion on the Dean’s List at Nanyang Technological University for the academic year 2018/2019, further attesting to his dedication and outstanding performance in his field.

Conclusion

Liew Yew Meng Royston demonstrates significant potential as a researcher with a strong interdisciplinary approach and innovative mindset. His proactive research efforts, combined with his engineering background, position him as a promising candidate for the Best Researcher Award. However, enhancing his publication record and securing research grants could further solidify his standing in the research community.

Publication Top Notes

Diagnostic laparoscopy for pre-operative selection of patients with known peritoneal carcinomatosis for CRS-HIPEC: A systematic review and meta-analysis

  • Authors: Ang, A.J.Y., Liew, R.Y.M., Aw, V.Z.J., Chia, C.S., Shannon, N.B.
  • Year: 2024
  • Journal: European Journal of Surgical Oncology
  • Volume: 50
  • Issue: 11
  • Article Number: 108623